Novel CD19/BCMA Dual-Targeted CAR-T Cell Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Novel CD19/BCMA Dual-Targeted CAR-T Cell Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma	Relapse Multiple Myeloma	Recruiting	Not applicable	2026-01-22		NCT07359014

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Jinhua Municipal Central Hospital	14
Second Affiliated Hospital, Zhejiang University, School of Medicine	561
Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University	28
Tongji Hospital	276

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Xuzhao Zhang	Hangzhou	China	1

Clinical trials